Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
J Ethnopharmacol ; 263: 113232, 2020 Dec 05.
Article in English | MEDLINE | ID: mdl-32768641

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: In Guinea, medicinal plants play an important role in the management of infectious diseases including urinary disorders, skin diseases and oral diseases. This study was carried out to collect medicinal plant species employed for the treatment of these diseases and to investigate their antimicrobial potential. MATERIALS AND METHODS: Based on an ethnobotanical investigation carried out in three Guinean regions, 74 traditional healers and 28 herbalists were interviewed and medicinal plants were collected. The most quoted plant species were evaluated for their antimicrobial activities against Staphylococcus aureus, Escherichia coli, Candida albicans, and in addition against Plasmodium falciparum. RESULTS: A total of 112 plant species belonging to 102 genera distributed over 42 botanical families were inventoried. Among the selected plant species, promising activities against C. albicans were obtained for the methanolic extracts of the stem bark of Terminalia albida (IC50 1.2 µg/ml), the leaves of Tetracera alnifolia (IC50 1.6 µg/ml) and the root bark of Swartzia madagascariensis (IC50 7.8 µg/ml). The highest activity against S. aureus was obtained for the dichloromethane extracts of the leaves of Pavetta crassipes (IC50 8.5 µg/ml) and the root of Swartzia madagascariensis (IC50 12.8 µg/ml). Twenty one extracts, obtained from twelve plant species, were strongly active against Plasmodium falciparum, including the dichloromethane extracts of the root and stem bark of Terminalia albida root (IC50 0.6 and 0.8 µg/ml), the leaves of Landolphia heudelotii (IC50 0.5 µg/ml), the stem bark of Combretum paniculatum (IC50 0.4 µg/ml) and the leaves of Gardenia ternifolia (IC50 1.3 µg/ml). CONCLUSION: The present study provides a comprehensive overview of medicinal plants employed by Guinean traditional healers for the treatment of various microbial diseases, including urinary disorders, skin diseases and oral diseases. Some of the studied plant species showed promising antimicrobial activity and could be considered as a potential source for the development of new antifungal and/or antimalarial agents.


Subject(s)
Anti-Infective Agents/pharmacology , Ethnobotany/methods , Medicine, African Traditional/methods , Plant Extracts/pharmacology , Plants, Medicinal , Anti-Infective Agents/isolation & purification , Ethnobotany/trends , Female , Fibroblasts/drug effects , Fibroblasts/microbiology , Guinea/ethnology , Humans , Male , Medicine, African Traditional/trends , Microbial Sensitivity Tests/methods , Plant Extracts/isolation & purification , Plasmodium falciparum/drug effects , Plasmodium falciparum/physiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/physiology
2.
Anthropol Med ; 27(1): 1-16, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31385715

ABSTRACT

During the 2013-2016 West African Ebola epidemic, medical emergency response teams negotiated a context marked by public hysteria and fear to prevent the spread of the virus and treat those already infected. However, the presence and work of Ebola response teams added to suspicions provoked by the rapid increase in numbers of dead and dying and by locally unintelligible emergency measures. Based on data collected from 40 young adult 'survivors' between 16 and 29 years of age who were hospitalized for Ebola during the epidemic, this article examines how pharmaceutical treatments were accepted (or not) by patients in ebola treatment units (ETU). Three key questions guide this analysis: (1) Did hospitalized individuals adhere with or refuse treatments offered at ETUs? (2) Did their attitudes change over the course of their hospitalization? (3) Which factors influenced refusal of treatment or compliance? To the authors' knowledge, no previous studies have explored the resistance of hospitalized patients to treatment in Ebola centers. This article, in addition to exploring patients' practices and related perceptions of treatment with evolving meanings in this outbreak crisis situation, also presents practical recommendations for future Ebola interventions as well as theoretical knowledge about the circulation and transformation of socially constructed representations of medications.


Subject(s)
Hemorrhagic Fever, Ebola , Medication Adherence , Adolescent , Adult , Anthropology, Medical , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Epidemics , Guinea/ethnology , Hemorrhagic Fever, Ebola/drug therapy , Hemorrhagic Fever, Ebola/ethnology , Hemorrhagic Fever, Ebola/psychology , Humans , Medication Adherence/ethnology , Medication Adherence/psychology , Public Opinion , Young Adult
3.
Hum Nat ; 30(4): 398-421, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31729693

ABSTRACT

Fairness is undoubtedly an essential normative concept in humans and promotes cooperation in human societies. The fact that fairness exists is puzzling, however, because it works against the short-term interest of individuals. Theories of genetic evolution, cultural evolution, and gene-culture coevolution identify plausible mechanisms for the evolution of fairness in humans. Such mechanisms include kin selection, the support of group-beneficial moral norms through ethnic markers, free partner choice with equal outside options, and free partner choice with reputation as well as spite in small populations. Here, we present the results of a common-pool resource game experiment on sharing. Based on data from 37 multiethnic villages in a subsistence agricultural population in Foutah Djallon, Guinea, we show that fair behavior in our experiment increased with increasing ethnic homogeneity and market integration. Group size and kinship had the opposite effect. Overall, fair behavior was not conditional on reputation. Instead, the ability of the different village populations to support individuals' fairness in situations lacking the opportunity to build a positive reputation varied significantly. Our results suggest that evolutionary theory provides a useful framework for the analysis of fairness in humans.


Subject(s)
Family/ethnology , Group Processes , Morals , Social Behavior , Social Perception , Adult , Guinea/ethnology , Humans
4.
Epilepsy Behav ; 92: 276-282, 2019 03.
Article in English | MEDLINE | ID: mdl-30731293

ABSTRACT

PURPOSE: The purpose of this study was to characterize the reasons, extent, and impact of traditional medicine use among people with epilepsy (PWE) in the Republic of Guinea. METHODS: Guinea is a low-income country in sub-Saharan Africa (SSA) with limited healthcare resources. People with epilepsy and their caregivers were seen at a public referral hospital in Conakry, the capital city, where they completed semi-structured interviews with physicians regarding their beliefs about epilepsy, medical care, and engagement with traditional healers. RESULTS: Of 132 participants (49% children, 44% female, 55% with a university-educated head of household), 79% had seen a traditional healer, and 71% saw a traditional healer before seeing a medical provider for their epilepsy. Participants were treated by a traditional healer for a mean of 39 months before seeing a medical provider. By contrast, 58% of participants reported taking antiepileptic drugs (AEDs) regularly; 46% reported having undergone a head computed tomography (CT) scan; 58% reported having had an electroencephalogram, and 4% reported having had a brain magnetic resonance imaging (MRI) scan. CONCLUSIONS: Traditional healers in Guinea provide frontline care for PWE in Guinea with considerable delays in AED initiation, even among a cohort of PWE actively seeking medical care. Engaging with these healers is critical for both influencing community perceptions and appropriately managing epilepsy throughout the country.


Subject(s)
Caregivers , Epilepsy/ethnology , Epilepsy/therapy , Medicine, African Traditional/methods , Adolescent , Adult , Anticonvulsants/therapeutic use , Caregivers/psychology , Child , Child, Preschool , Cohort Studies , Electroencephalography/methods , Epilepsy/diagnostic imaging , Female , Guinea/ethnology , Humans , Male , Referral and Consultation , Young Adult
9.
Rev Neurol ; 59(4): 153-7, 2014 Aug 16.
Article in Spanish | MEDLINE | ID: mdl-25059265

ABSTRACT

INTRODUCTION: Sickle-cell anaemia is the severe homozygotic form of drepanocytosis, a genetic disorder that often occurs among black people and which is characterised by the production of haemoglobin S, chronic hemolytic anaemia and tissue ischaemia due to alterations in blood flow. A quarter of the patients presented neurological manifestations; 8-10% of children will have a stroke. AIM. To analyse the cases of stroke in children with sickle-cell anaemia in our centre. PATIENTS AND METHODS: We conducted a retrospective descriptive study of children with sickle-cell anaemia and stroke. RESULTS: Five patients (two Dominicans and three Guineans) with sickle-cell anaemia and stroke; one patient suffered two episodes of stroke. The mean age was 27 months. Five of the episodes were ischaemic infarctions. Stroke was the initial form of presentation of drepanocytosis on three occasions. Two of the strokes occurred within a context of pneumococcal meningitis. Four of the patients had previously reported fever. The initial clinical picture was hemiparesis in four cases. Mean haemoglobin on diagnosing the stroke was 6.5 g/dL. Transcranial ultrasound imaging revealed alterations in three patients and, in all the patients, magnetic resonance imaging revealed lesions, which were bilateral in half the cases. Following the stroke, a hypertransfusion regimen protocol was established and only one patient presented a new stroke. This same patient went on to develop moya-moya disease and was submitted to an indirect revascularisation; the patient progressed well, without presenting any new ischaemic events. CONCLUSIONS: Drepanocytosis is a disease that is emerging in our setting as a result of immigration. It should be suspected in cases of paediatric strokes associated to anaemia, above all in black children under the age of five who were not submitted to neonatal screening.


TITLE: Ictus en pacientes pediatricos con anemia falciforme.Introduccion. La anemia falciforme es la forma homocigota, grave, de drepanocitosis, un trastorno genetico, frecuente en raza negra, caracterizado por la produccion de hemoglobina S, anemia hemolitica cronica e isquemia tisular por alteracion del flujo sanguineo. Una cuarta parte de los pacientes presenta manifestaciones neurologicas; el 8-10% de los niños sufrira un ictus. Objetivo. Analizar los casos de ictus en niños con anemia falciforme en nuestro centro. Pacientes y metodos. Estudio descriptivo retrospectivo de niños con anemia falciforme e ictus. Resultados. Se recogieron cinco pacientes (dos dominicanos y tres guineanos) con anemia falciforme e ictus; un paciente sufrio dos episodios ictales. La edad media fue de 27 meses. Cinco episodios fueron infartos isquemicos. El ictus fue la forma de inicio de la drepanocitosis en tres ocasiones. Dos de los ictus ocurrieron en un contexto de meningitis neumococica. En cuatro pacientes hubo fiebre previa. La clinica inicial fue hemiparesia en cuatro casos. La hemoglobina media al diagnostico de ictus fue de 6,5 g/dL. En tres pacientes se hallaron alteraciones en la ecografia transcraneal y, en todos los pacientes, lesiones en la resonancia magnetica, que en la mitad eran bilaterales. Tras el ictus se inicio un protocolo de regimen hipertransfusional, y solo un paciente presento un nuevo ictus, que desarrollo un sindrome moya-moya y fue sometido a una revascularizacion indirecta, con buena evolucion, sin presentar nuevos eventos isquemicos posteriores. Conclusiones. La drepanocitosis es una enfermedad emergente en nuestro medio debido a la inmigracion. Debe sospecharse en ictus pediatricos asociados a anemia, sobre todo en menores de 5 años de raza negra no sometidos a cribado neonatal.


Subject(s)
Anemia, Sickle Cell/complications , Brain Ischemia/etiology , Anemia, Sickle Cell/epidemiology , Brain/pathology , Cerebral Hemorrhage/etiology , Cerebrovascular Circulation , Child, Preschool , Dominican Republic/ethnology , Emigrants and Immigrants , Exchange Transfusion, Whole Blood , Female , Guinea/ethnology , Humans , Infant , Male , Meningitis, Pneumococcal/complications , Moyamoya Disease/etiology , Moyamoya Disease/surgery , Neuroimaging , Paresis/etiology , Respiratory Tract Infections/complications , Retrospective Studies , Spain/epidemiology
11.
Dermatol Online J ; 17(10): 22, 2011 Oct 15.
Article in English | MEDLINE | ID: mdl-22031648

ABSTRACT

A 36-year-old African man from Guinea with a history of albinism presented with a many-year history of scaling and erythema of the face, neck, and arms. The patient had light eyes, hair, and skin. Physical examination showed extensive photodamage. A skin biopsy specimen from the posterior aspect of the lower leg showed a squamous-cell carcinoma in situ. The most common types of oculocutaneous albinism (OCA), OCA 1 and OCA 2, are autosomal recessive disorders of pigmentation that commonly affect the skin, hair, eyes, and ears. Photodamage and skin cancers plague patients with albinism. In Africa, where albinism is prevalent, albinos face a myriad of social and medical issues. Skin cancer surveillance is an important consideration for albinos, and sun protection is paramount.


Subject(s)
Albinism, Oculocutaneous/complications , Carcinoma in Situ/etiology , Carcinoma, Squamous Cell/etiology , Neoplasms, Radiation-Induced/etiology , Skin Neoplasms/etiology , Sunlight/adverse effects , Adult , Albinism, Oculocutaneous/ethnology , Albinism, Oculocutaneous/genetics , Albinism, Oculocutaneous/psychology , Carcinoma in Situ/diagnosis , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/pathology , Disease Susceptibility , Guinea/ethnology , Humans , Leg , Male , Neoplasms, Radiation-Induced/diagnosis , Neoplasms, Radiation-Induced/pathology , Prejudice , Prevalence , Radiation Tolerance/genetics , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Sunburn , Sunscreening Agents
13.
Med Mal Infect ; 41(9): 475-9, 2011 Sep.
Article in French | MEDLINE | ID: mdl-21295427

ABSTRACT

South Western islands of the Indian Ocean are permanently threatened by dengue fever outbreaks. On the Reunion Island, two dengue outbreaks were biologically documented (1977-1978 and 2004). And since July 2004 there has been an inter-epidemic period for the island with sporadic cases and clusters. Between January 1, 2007 and October 5, 2009, the epidemiologic surveillance system detected five confirmed autochthonous cases, five confirmed imported cases (South-East Asia), and 71 probable cases. All the five autochthonous confirmed cases occurred in Saint-Louis during two consecutive clusters. In other South Western islands of the Indian Ocean, several dengue fever outbreaks have been reported. Importation of dengue virus from South-East Asia is a major risk for a new outbreak on the island. The introduction of a new serotype could lead to the emergence of new and severe clinical forms, including dengue hemorrhagic fever.


Subject(s)
Dengue/epidemiology , Disease Outbreaks , Aedes/virology , Animals , Asia, Southeastern/ethnology , Dengue Virus/classification , Dengue Virus/isolation & purification , Guinea/ethnology , Humans , Indian Ocean Islands/epidemiology , Insect Vectors/virology , Madagascar/ethnology , Mandatory Reporting , Population Surveillance , Reunion/epidemiology , Serotyping , Travel
15.
Ann Dermatol Venereol ; 137(5): 359-63, 2010 May.
Article in French | MEDLINE | ID: mdl-20470916

ABSTRACT

BACKGROUND: With 254,525 new cases reported in 2007, leprosy is the worlds' second most widespread form of mycobacteriosis. According to the WHO, eradication of leprosy as a public health problem (defined by less than one case per 10,000 people) has been globally achieved. High endemic zones, however, still subsist. Leprosy rates among children, which reflect a country's endemic level, ranged from 0.55 to 19.2 % in 2006. Due to world population migrations, cases of leprosy are now seen in mainland France, in both children and adults. PATIENTS AND METHODS: We describe three leprosy patients aged under 15 years treated at the Dermatology Unit of Saint Louis Hospital between 1st January 2002 and 31st December 2008. The three cases described account for 3 % of new patients treated for leprosy at Saint Louis Hospital over this 7-year period. All were born in an endemic country. Lesions appeared 18 months after arrival in France in two cases and clinical diagnosis was made in only one case. Due to absence of sensory loss in the lesions, diagnosis was reliant upon histopathological examination in two cases. CONCLUSION: Leprosy should be suspected in children from endemic countries presenting skin lesions, particularly hypochromic lesions, even if there is no sensory loss, regardless of how long they have been living in France.


Subject(s)
Leprosy/diagnosis , Adolescent , Adrenal Cortex Hormones/therapeutic use , Age of Onset , Biopsy , Brazil/ethnology , Child , Drug Therapy, Combination , Endemic Diseases , Female , France/epidemiology , Guinea/ethnology , Humans , India/ethnology , Leprosy/drug therapy , Leprosy/epidemiology , Leprosy/pathology , Male , Retrospective Studies , Rifampin/therapeutic use , Skin/pathology
16.
Acta Chir Belg ; 108(5): 590-1, 2008.
Article in English | MEDLINE | ID: mdl-19051473

ABSTRACT

Gastroduodenal tuberculosis (TB) is a rare condition and is often associated with pulmonary TB. We report the case of a primary duodenal TB in an immunocompetent patient without evidence of pulmonary TB. Diagnosis of this disease is difficult and is often confused with chronic peptic ulcer disease. Literature data concerning this challenging diagnosis are analysed.


Subject(s)
Duodenal Diseases/diagnosis , Tuberculosis, Gastrointestinal/diagnosis , Abdominal Pain/etiology , Adult , Antitubercular Agents/therapeutic use , Duodenal Diseases/drug therapy , Duodenal Diseases/microbiology , Guinea/ethnology , Heartburn/etiology , Humans , Male , Tuberculosis, Gastrointestinal/drug therapy , Young Adult
17.
Pathol Biol (Paris) ; 56(5): 314-8, 2008 Jul.
Article in French | MEDLINE | ID: mdl-18343605

ABSTRACT

A 54-years-old patient coming from Guinea, who presented fever, diarrhoea, consciousness disorders and severe haemolytic anaemia, was admitted to resuscitation unit in France. Despite many explorations carried out (evaluation of traumatic causes, infection, neoplasia, vascular, toxic causes, vitamin deficiency), it was not possible to explain neurological symptomatology. Besides, haemolytic anaemia was due to the ingestion of metamizole in a context of glucose-6-phosphate dehydrogenase deficit. This drug's marketing has been suspended in France since 2006. Despite appropriate treatment, after seven days of hospitalization, the patient died of multi-organ failure and hemophagocytic syndrome. This clinical case illustrates the difficulties encountered to set a diagnosis and manage patients coming from overseas. Uncommon aetiologies for French healthcare professionals should be evoked in the absence of comprehensive clinical information.


Subject(s)
Anemia, Hemolytic/etiology , Antithyroid Agents/adverse effects , Glucosephosphate Dehydrogenase Deficiency/diagnosis , Methemoglobinemia/chemically induced , Methimazole/adverse effects , Psychomotor Agitation/etiology , Diagnosis, Differential , Diarrhea/etiology , Fatal Outcome , Glucosephosphate Dehydrogenase Deficiency/complications , Guinea/ethnology , Headache/etiology , Humans , Lymphohistiocytosis, Hemophagocytic/etiology , Malaria, Falciparum/diagnosis , Male , Methemoglobinemia/etiology , Middle Aged , Multiple Organ Failure/etiology , Paris , Seizures/etiology , Vomiting/etiology
19.
Rev Mal Respir ; 23(2 Pt 1): 157-60, 2006 Apr.
Article in French | MEDLINE | ID: mdl-16788441

ABSTRACT

INTRODUCTION: Antituberculous treatment is effective but has numerous side effects. Among these isoniazid induced neuropathy is easily preventable. CASE REPORT: A female patient of 42 years, infected with HIV, presented with general deterioration associated with an interstitial pulmonary infiltrate and mediastinal lymphadenopathy. Tuberculosis was not confirmed bacteriologically but she responded to antituberculous treatment. Three months later she developed distal leg pains extending proximally. There was superficial sensory impairment up to the groins and loss of the ankle reflexes. The dose of isoniazid was reduced from 5 to 2.5 mg/kg/day on account of slow acetylator status and treatment with pyridoxine 250 mg/day commenced. The clinical signs resolved in a few weeks. CONCLUSIONS: Isoniazid neuropathy develops in the presence of risk factors (HIV, alcoholism, diabetes, renal failure, malnutrition, pregnancy and lactation, neurotoxic medication) and manifests itself initially by burning feet. Pyridoxine is preventative in low dosage and curative in high dosage. The development of symptoms should lead to measurement of acetylator status, and a reduction of the isoniazid dose to 3 mg/kg/day or even less in slow acetylators.


Subject(s)
Antitubercular Agents/adverse effects , Isoniazid/adverse effects , Peripheral Nervous System Diseases/chemically induced , Vitamin B 6 Deficiency/chemically induced , Vitamin B 6/therapeutic use , Acetylation , Achilles Tendon , Adult , Antiretroviral Therapy, Highly Active , Antitubercular Agents/pharmacokinetics , Antitubercular Agents/therapeutic use , Ethambutol/administration & dosage , Ethambutol/therapeutic use , Female , Guinea/ethnology , HIV Infections/complications , HIV Infections/drug therapy , Hepatitis B, Chronic/complications , Humans , Hypesthesia/chemically induced , Hypesthesia/drug therapy , Hypesthesia/prevention & control , Inactivation, Metabolic/genetics , Isoniazid/administration & dosage , Isoniazid/pharmacokinetics , Isoniazid/therapeutic use , Peripheral Nervous System Diseases/drug therapy , Peripheral Nervous System Diseases/prevention & control , Reflex, Abnormal/drug effects , Rifampin/administration & dosage , Rifampin/therapeutic use , Tuberculosis, Pulmonary/drug therapy , Vitamin B 6/pharmacokinetics , Vitamin B 6 Deficiency/drug therapy , Vitamin B 6 Deficiency/prevention & control
SELECTION OF CITATIONS
SEARCH DETAIL
...